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Summary
We have conducted a genome screen of autism, by link-
age analysis in an initial set of 90 multiplex sibships,
with parents, containing 97 independent affected sib
pairs (ASPs), with follow-up in 49 additional multiplex
sibships, containing 50 ASPs. In total, 519 markers were
genotyped, including 362 for the initial screen, and an
additional 157 were genotyped in the follow-up. As a
control, we also included in the analysis unaffected sibs,
which provided 51 discordant sib pairs (DSPs) for the
initial screen and 29 for the follow-up. In the initial
phase of the work, we observed increased identity by
descent (IBD) in the ASPs (sharing of 51.6%) compared
with the DSPs (sharing of 50.8%). The excess sharing
in the ASPs could not be attributed to the effect of a
small number of loci but, rather, was due to the modest
increase in the entire distribution of IBD. These results
are most compatible with a model specifying a large
number of loci (perhaps 15) and are less compatible
with models specifying 10 loci. The largest LOD score
obtained in the initial scan was for a marker on chro-
mosome 1p; this region also showed positive sharing in
the replication family set, giving a maximum multipoint
LOD score of 2.15 for both sets combined. Thus, there
may exist a gene of moderate effect in this region. We
had only modestly positive or negative linkage evidence
in candidate regions identified in other studies. Our re-
sults suggest that positional cloning of susceptibility loci
by linkage analysis may be a formidable task and that
other approaches may be necessary.
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Introduction
Autism (MIM 209850) is a pervasive neurodevelop-
mental disorder with symptoms usually apparent during
the first 3 years of life. It is characterized by a triad of
features, including limited or absent verbal communi-
cation, a lack of social reciprocity or responsiveness, and
limited, stereotypical, and ritualized interests and be-
haviors. Autism is the most severe of the disorders now
characterized as “pervasive developmental disorders”
(PDD) (MIM 209850), which also include Asperger syn-
drome (MIM 209850) and PPD that is not otherwise
specified (PDD-NOS).
Autism was first typified as a distinct clinical entity
by Kanner (1943). The etiology of this syndrome has
been debated ever since, with various proponents fa-
voring behavioral, environmental, dietary, viral/immu-
nologic, autoimmune, or genetic theories. On the basis
of the prevalence studies that have been performed, the
indication is that autism is generally rare, with a mean
prevalence of 1/2,500 children (Smalley et al. 1988).
The infrequency of familial cases of autism probably
led some early theorists to doubt an inherited component
in this disorder (Hanson and Gottesman 1976). For ex-
ample, for a typical rare recessive disease, multiple-in-
cidence sibships are not unusual, since the recurrence
risk in sibships is 25%. The recurrence risk of autism
in sibships is far below that 25% figure. However, with
the completion of several systematic family studies, it is
now possible to provide a consistent sibling recurrence
figure of 2%–6%, which is substantially higher than the
population prevalence of 1/2,500, or 0.04% (Smalley et
al. 1988; Bolton et al. 1994). The most recent summary
of family studies provided an overall sibling recurrence
risk of 2.2% (13/597), with a 95% confidence limit of
1.1%–3.3% (Szatmari et al. 1998). Thus, although fa-
milial cases are rare, they are substantially more frequent
than would be predicted to occur by chance.
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Further supporting a genetic etiology in autism are the
results of twin studies, which have documented a dra-
matically higher concordance rate in MZ twins than in
DZ twins (Folstein and Rutter 1977). Summarizing the
largest and most systematic of these studies (Steffenburg
et al. 1989; Bailey et al. 1995), we can derive MZ-twin
and DZ-twin probandwise concordances of 81% (47/
58) and 0%, respectively, for autism. The latter figure
is likely to be an underestimate as a result of small sam-
ple sizes, and the true DZ-twin concordance is likely to
be similar to the nontwin-sib rate of 2%–6%. Using a
3% rate gives an MZ-twin concordance:DZ-twin con-
cordance ratio (MZ:DZ concordance ratio) of ∼25-fold.
We note that, whereas the sib recurrence is based on
numerous studies and a sizable total sibling population
( ), the MZ-twin concordance rate is based on an  597
much smaller sample and thus is more susceptible to
statistical fluctuation. Nonetheless, it is likely that the
MZ:DZ concordance ratio in autism is quite large.
Autistic features have also been described in individ-
uals with well-characterized genetic disorders, most no-
tably fragile X syndrome (FMR1 [MIM 309550]) (Fein-
stein and Reiss 1998) and tuberous sclerosis (TSC1
[MIM 191100]) (Smalley 1998). In addition, case studies
have been reported that show associations between au-
tism and a variety of isolated chromosomal transloca-
tions, inversions, and deletions (Gillberg 1998). These
findings provide evidence that genetic abnormalities can,
in some cases, produce behaviors typical of autism, but
they account for only a small percentage of cases and
do not explain the familial aggregation of autism.
Autism does not follow a simple mode of inheritance.
Genealogical studies suggested an increased risk pri-
marily in close relatives (sibs) (Jorde et al. 1990), and a
reported segregation analysis was most consistent with
a polygenic model of inheritance (Jorde et al. 1991).
These results suggest that family recurrence is unlikely
to be explained by a simple, monogenic mechanism.
The first linkage study in autism was performed by
Spence et al. (1985), using 20 classic blood-group and
serum-protein markers on 34 multiplex sibships and as-
suming a recessive model. No significant linkage findings
were obtained.
Recent advances in molecular biology have allowed
genome surveys for disease-susceptibility loci to be per-
formed on a much larger scale. For example, Hallmayer
et al. (1996) examined 35 microsatellite markers on the
X chromosome in 38 multiplex autism families. Al-
though they excluded most of the chromosome from
carrying a gene of large effect, including the fragile X
region, they found modest evidence (maximum LOD
score 1.24) for linkage in one region on proximal Xq.
A genome screen of the full genome, using 316 mi-
crosatellite markers on 39 multiplex families, has also
been reported recently (International Molecular Genetic
Study of Autism Consortium 1998). Initial positive find-
ings were followed up in an additional 60 families. No
statistically significant findings were obtained. The most
positive finding was a LOD score of 2.53, on chromo-
some 7q, with the next most positive finding being a
LOD score of 1.97, near the telomere of chromosome
16p.
In this report we describe the results of what, to date,
is the largest genome screen in autism. We have surveyed
90 multiplex sibships with 97 independent affected sib
pairs (ASPs) in an initial analysis of 362 microsatellite
markers. Regions with positive results, as well as other
candidate regions, were then followed up with addi-
tional markers, as well as by analysis of a second set of
49 multiplex sibships containing 50 independent ASPs.
A total of 519 markers was analyzed in the first set of
families, and 149 of these markers were also analyzed
in the second set of families.
Families And Methods
Family Recruitment and Diagnostic Assessments
Families were recruited nationwide for this study, by
advertisement with local and national parent support
groups and by referrals from clinicians. Initial intake
criteria required that at least two siblings have a clinical
diagnosis of a PDD. If both the initial telephone intake
interview of parents and collected medical records were
consistent with a presumptive diagnosis of autism in at
least two children, then a follow-up visit by a diagnos-
tician was arranged with the family. During these visits,
the children were assessed—both by interview, of one
or both parents, using the Autism Diagnostic Interview
(ADI) (LeCouteur et al. 1989; Lord et al. 1994, 1997),
and by observation of the children, using the Autism
Diagnosis Observation Schedule (ADOS) (Lord et al.
1989)—to determine a research diagnosis of autism. The
ADI is a scored, semistructured interview of parents that
is based on ICD-10 and DSM-IV criteria for the diag-
nosis of autism. The ADOS is a semistructured instru-
ment, which allows assessment of the child through ob-
servation of his or her behavior and which is used to
corroborate the results of the ADI interview. Diagnostic
assessments (by ADI and ADOS) were videotaped and
subjected to independent reliability checks by other
trained interviewers (typically, the senior clinical inves-
tigators). To be considered affected in the linkage anal-
ysis, an individual had to satisfy the prespecified cutoff
scores in all three symptom areas of the ADI (social
impairment, language and communication impairment,
and unusual and restricted interests) as well as have an
age at onset of !3 years. In addition, review of the ADOS
tape by two or more diagnosticians was used to exclude
children who did not show significant impairments in
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Table 1
Distribution of Family Structures
GROUP AND NO.
OF AFFECTED SIBS
NO. OF
Unaffected
Sibs
Available
Parents Families
FS1:
2 0 2 48
2 0 1 15
2 1 2 13
2 1 1 5
2 2 2 2
2 3 1 2
3 0 2 2
3 1 2 1
4 0 2 1
4 1 1 1
FS2:
2 0 2 34
2 0 1 1
2 1 2 12
2 2 2 1
3 1 2 1
Table 2
Markers with Highest Sharing in ASPs and DSPs
in Initial Genome Screen
Marker No. (%) Sharing Z Score
ASPs:
D1S1631 80/122 (65.6) 3.44
D13S779 64/101 (63.4) 2.69
D9S282 60/95 (63.2) 2.66
D1S1609 79/130 (60.8) 2.46
D3S2418 60/96 (62.5) 2.45
D17S1298 51/81 (63.0) 2.33
D15S652 79/132 (59.8) 2.26
D10S1412 53/86 (61.6) 2.16
D1S534 81/137 (59.1) 2.14
DSPs:
GATA145D0 34/49 (69.4) 2.71
D16S403 42/63 (66.7) 2.65
D18S844 39/60 (65.0) 2.32
D16S3253 29/43 (67.4) 2.29
D7S1819 35/54 (65.3) 2.18
D4S2361 32/49 (65.3) 2.08
D11S2371 26/39 (66.7) 2.08
D4S2366 34/53 (64.2) 2.06
D20S482 31/48 (64.6) 2.02
D16S769 32/50 (64.0) 1.98
social and communicative reciprocity, irrespective of the
results of the ADI interview (e.g., this would lead to the
exclusion of some individuals who would have had a
clinical diagnosis of PDD-NOS). Families were excluded
from subsequent analysis if, on the basis of all available
information, there was no consensus that at least two
affected children had deficits consistent with a diagnosis
of autism. For more details on the diagnostic protocol
and reliability of videotapes of the ADI assessments, see
the work of Spiker et al. (1994).
Children’s records were reviewed to obtain IQ and
mental-age (MA) information. When available, nonver-
bal IQ scores were obtained from performance subtests
of either the Wechsler Scales or the Stanford-Binet In-
telligence Scale-4th Edition, from the Leiter Interna-
tional Performance Scale, or from the Merrill-Palmer
Scale. When unavailable, scores from such tests as the
Stanford-Binet Intelligence Scale-3rd Edition, Slossen In-
telligence Scale, or McCarthy Scales were used. For chil-
dren for whom results of these tests were not available,
MAs and ratio IQ scores were derived from nonverbal
scales of various developmental instruments (e.g., Daily
Living Scale of the Vineland Adaptive Behavior Scale,
the Bayley Mental Scale, and Developmental Inventory
II).
For inclusion in the linkage analysis, we also required
that at least one affected child have both an MA of18
mo and a nonverbal IQ 30. This led to the exclusion
of some additional families ( ) in which all childrenN  6
were severely impaired (MA !18 mo and IQ !30).
Two-Stage Analysis
Families were analyzed in two stages. The initial stage
involved genotyping of family set 1 (FS1), which in-
cluded 90 multiplex families. These families comprise a
total of 187 affected and 30 unaffected sibs; 67 families
have two parents available, and the remaining 23 have
one parent. The precise breakdown of family structures
is given in table 1. Among the affected sibs, the male:
female ratio is 3.6:1, whereas in the unaffected sibs it is
0.8:1.
Subsequent to the initial genome screen performed on
FS1, a follow-up study was conducted on a second fam-
ily set (FS2), which comprises a total of 49 multiplex
families, ascertained in a manner similar to that used
with FS1. These families contain a total of 99 affected
and 15 unaffected sibs; 48 of the 49 families have both
parents available, whereas the single remaining family
has one parent. The precise breakdown, by family struc-
ture, is given in table 1. The male:female ratio in the
affected sibs is 3.0:1, versus 0.7:1 in the unaffected sibs.
Laboratory Procedures
Blood was collected from all affected individuals and,
if available, from their parents and unaffected siblings.
Blood samples were drawn into Vacutainer sodium hep-
arin (green cap) tubes. The lymphoblasts were isolated
and immortalized with fresh or frozen virus stocks, by
standard Epstein-Barr–virus transformation protocols
(Anderson and Gusella 1984). The DNA was extracted
from both whole blood and immortalized lymphoblast
cell lines, by standard proteinase K–digestion and salt-
ing-out procedures.
Genotyping was performed in two laboratories in-
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dependently, according to somewhat different proce-
dures. In one lab, PCR was performed, by Perkin-Elmer
9700 thermal cyclers, in a 10-ml volume in 96-well plates
and included 30 ng of genomic DNA, 67 mM Tris-HCl
pH 8.8, 200 mM of each dNTP, 16 mM (NH4)2SO4,
0.01% Tween-20, 1.5–3 mM MgCl2, 0.2 mM of each
primer, and 0.2 units of AmpliTaq polymerase (Perkin-
Elmer). The forward primers for each marker were flu-
orescently labeled with FAM, HEX, or TET dyes. The
reaction was first denatured for 75 s at 95C; then, 35
cycles of 45 s at 95C, 45 s at 57 C, and 60 s at 72
C were performed, followed by a final elongation step
of 7–12 min at 72 C. PCR products were pooled from
∼7–15 markers that were separable on the basis of size
and dye color and were run on ABI Prizm 377 DNA
sequencers. Tamara-labeledDNA internal-size standards
were run in each lane, and the products were resolved
by the GeneScan and Genotyper software packages from
Applied Biosystems. Three CEPH control DNAs from
individuals 1331-01, 1331-02, and 1347-02 were used
to verify the sizes of PCR products for each marker.
In the second lab, PCR assays were performed in 8-
ml reactions containing 10 ng of genomic DNA; 2.5 mM
of each dNTP; 0.2–0.6 mM of each primer pair labeled
with the fluorescent dyes FAM, HEX, or TET; 0.8 ml of
10# buffer (Perkin-Elmer); 1.5–2.5 mMMgCl2, and 0.2
units of AmpliTaq Gold Polymerase (Perkin-Elmer).
PCR assays were performed in an Applied Biosystems
9600 Thermocycler by denaturation for 10 min at 94C,
15 s at 60C, and 15 s at 72C. Another 20 cycles of
30 s at 94C, 15 s at 65C, and 15 s at 72C were
performed, and these were followed by a final extension
step of 10 min at 72C. Fluorescently labeled markers
were analyzed on an Applied Biosystems 373 Genetic
Analyzer, by Genescan and Genotyper software. In both
labs, polymorphic bands were scored, and alleles were
assigned to the pedigree members, by researchers who
were blind to affection status.
Genetic Markers
Marker set 1 (MS1).—The genetic analysis was per-
formed in two stages. The first stage consisted of a ge-
nome screen on the 90 multiplex FS1 families and used
a total of 362 microsatellite markers. These were derived
from version 8.0 of the Marshfield fluorescently labeled
genome screening set (Center for Medical Genetics,
Marshfield Medical Research Foundation) and were ob-
tained from Research Genetics. Of these markers, 346
are autosomal, 14 are X linked, and 2 are pseudoau-
tosomal. If a sex-averaged total autosomal map length
of 3,500 cM is assumed, the average spacing between
markers for the autosomal component is 10 cM; if a
length of 180 cM for the X chromosome is assumed,
the average spacing on that chromosome is 12 cM. Of
the intermarker intervals, 28 have an interval length 115
cM, although only 7 are 120 cM; the largest gap is 23
cM.
Marker set 2 (MS2).—Additional microsatellite mark-
ers were obtained from Research Genetics and were an-
alyzed subsequent to the initial genome screen. The
choice of markers was based on (1) saturation of regions
giving positive linkage evidence in the analysis of FS1
with MS1; (2) follow-up of specific regions, on the basis
of either candidate loci (chromosome regions 6p and
15q) or the genome screen of the International Molec-
ular Genetic Study of Autism Consortium (1998) (chro-
mosome region 7q); and (3) addition of markers in
regions that had large gaps in the initial screen withMS1
and that did not have significantly negative linkage ev-
idence in the preliminary analysis. In total, 157 addi-
tional markers were typed, which constituted MS2. All
of these markers were typed in FS1; 89 of these were
also typed in FS2. In addition, 60 of the original MS1
markers were genotyped in FS2 in the follow-up, for
reasons (1) and (2) above. Thus, in total, 519 markers
were typed in FS1, and 149 were typed in FS2.
Statistical Analysis
Linkage analysis.—Because all siblings had at least one
parent available and most had both parents available,
the statistical analyses were based entirely on identity by
descent (IBD), obviating the need to use allele frequen-
cies of the parents. When one parent is missing, a sib
pair can be scored for IBD with the included parent,
without bias, provided that the typed parent is hetero-
zygous and that each of the two sibs inherits from the
untyped parent an allele that is distinct from the alleles
of the typed parent. Also, sharing from the untyped par-
ent was scored, when possible, by reconstruction of the
genotype of the missing parent, by use of one affected
sib and all unaffected sibs (in the ASP analysis). If the
genotype of the parent can be so reconstructed, then
unbiased scoring can be performed by comparison of
the affected sib with each remaining affected sib, who
was not used for reconstruction.
Sib-pair analyses were based on fully independent
pairs. When a family contained three or more affected
sibs, independent pairs were formed between the first
sib and each remaining sib (giving pairs for a fam-n 1
ily with n affected sibs). In the 90 multiplex FS1 families,
there are thus a total of 97 independent ASPs; in the 49
multiplex FS2 families, there are 50 independent ASPs
(see table 1).
Initially, the number of alleles shared versus the num-
ber of alleles unshared, at each marker across sib pairs,
was evaluated and compared to a x2 distribution. Under
the null hypothesis of no linkage, the expectation is that
sharing will be 50%. Subsequently, multipoint sib-pair
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analysis was performed to extract the maximum infor-
mation from the genetic-marker data. This analysis is
parameterized in terms of the value lS, the sibling re-
currence ratio, which translates into specific values for
ASP IBD. For a genetic model with no dominance var-
iance, the probability z0 of an ASP sharing no alleles IBD
is .25/lS, the probability z1 of an ASP sharing one allele
IBD is .50, and the probability z2 of an ASP sharing two
alleles IBD is ; the overall sharing is1.25(2 ) y lS
. For a multiplicative model which allows1.25(3 )lS
dominance variance, again , ,.25 1z  z  ( l  )/l0 1 S Sl 2S
and ; the overall sharing is1 2z  (1 l ) y  12 S2
. We use the latter model in all the multipoint anal-1lS2
yses that we present, although, for modest gene effects,
results are nearly identical in either model.
Multipoint LOD scores can be calculated for a fixed
model (i.e., fixed value of lS); this approach allows for
exclusion mapping. For a fixed value of lS, negative
LOD scores can be obtained if the model gives a poorer
representation of the marker data than does no gene
effect. We use the LOD-score criterion of 2 for exclu-
sion of a locus with a given lS value; this provides a
conservative exclusion level (Hauser et al. 1996). Alter-
natively, the likelihood of the marker data can be max-
imized at each point, as a function of the genetic model
(lS value), to derive a maximumLOD score (MLS) curve.
This curve never drops to !0, the value obtained when
.l  1S
Linkage-disequilibrium analysis (LD).—We also ex-
amined LD, with all 519 autosomal and X-linked loci,
using a transmission/disequilibrium test (TDT) (Spiel-
man et al. 1993). For families with both parents, we
scored directly transmissions to all affected children
from heterozygous parents. As in the linkage analysis,
we can still score children from single parents, provided
that the parent is heterozygous and that the child is
heterozygous for alleles different than those in the typed
parent. We can also score transmissions from themissing
parent when the genotype of that parent can be recon-
structed on the basis of the unaffected sibs.
We examined two statistical tests—a “global x2”
(GCS) test, which sums X  (observedexpected)2/ex-
pected across each allele tested, and a “maximum x2”
(MCS) test, which takes the maximum value of the sta-
tistic X across all tested alleles. In this case, neither sta-
tistic has a formal x2 distribution when multiple sibs
from the same family are tested, if linkage is present
(Spielman et al. 1993). To make our test of LD inde-
pendent of any linkage present, we calculated the level
of significance empirically, using Monte Carlo simula-
tion; we simply randomly inverted or not, with proba-
bility 50%, the allele label for the two alleles of hetero-
zygous parents and recalculated the two statistics for
each permutation step. The proportion of simulated sta-
tistics that exceed the observed value is the derived em-
pirical significance level. This procedure allows us to
assess LD, conditional on the degree of sharing of alleles,
at a given locus, by sibs from multiplex families (Martin
et al. 1997; Lazzeroni and Lange 1998).
Computer program.—All statistical analysis, including
the pointwise and multipoint sib-pair analyses and the
TDT analyses, were performedwith the ASPEXprogram
package. We also used this package to confirm relation-
ships among study subjects and to search for and elim-
inate unlikely double crossovers in the multipoint anal-
yses, in regions that had dense markers.
Controls
In the course of this study, a number of controls were
employed, to determine the degree to which potential
biases might be confounding our results. After ∼60
markers were run in FS1, we examined the distribution
of IBD for all sib pairs, to confirm the presumed rela-
tionships, identify any mixup of samples, and identify
any potential half-sibs. All families segregated appro-
priately according to presumed relationships (no half-
sibs were identified), with the exception of two sib pairs,
in which IBD was nearly 100%. These pairs were re-
ported to us to be DZ twins, whereas our genotyping
determined them to be MZ. We left these twin pairs in
the analysis, both as a positive control and to determine
the genotyping-error rate. The lab remained blind to the
identity of these pairs.
As another control for our genetic analyses, we also
included unaffected sibs in our molecular and statistical
analyses. FS1 contains 30 unaffected sibs, which allowed
us to construct 51 independent affected-unaffected sib
pairs, or DSPs. These were derived by pairing, in each
family, one unaffected sib with each affected sib. Re-
maining unaffected sibs were used for reconstruction of
the genotypes of untyped parents. This selection scheme
allowed us to tally IBD for these pairs as fully indepen-
dent. Because of the typically modest recurrence risk of
autism in sibships (Smalley et al. 1988), we assume that
the DSPs should deviate little from the null expectation
of 50% sharing—and that they thus can serve as a useful
negative control.
Results
Family Recruitment
The first stage of analysis included the 90 multiplex
FS1 families comprising 187 affected offspring, 30 un-
affected sibs, and 157 parents. Two additional families
with affected MZ twins (originally thought to be DZ)
were also included. At the time of ADI administration,
the age range of the affected siblings was 2.9–40.9 years
(mean 9.8 years, SD 7.3 years, 25th–75th percentile
4.9–11.3 years). MA and IQ estimates were determined
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Figure 1 Observed distribution of Z scores for sharing at 346
autosomal marker loci in ASPs and DSPs, compared with the expected
distribution under no linkage. The thin unbroken line represents no
linkage; the thick dashed line represents sharing for ASPs; the thick
dotted line represents sharing for DSPs.
on the basis of available diagnostic evaluations and
school records. The mean nonverbal IQ was 66 (SD 28,
range 16–160). One hundred eight subjects (57%) had
IQ scores !70. The mean MA was 68 mo (SD 55 mo,
range 13–373 mo). There were no families in which all
affected children had IQ scores !30. In one family, one
affected child had an MA of !18 mo.
The second set of study subjects, obtained with similar
recruitment and inclusion/exclusion criteria, comprised
a total of 99 affected children, 15 unaffected sibs, and
97 parents, from 49 families. For this group, at the time
of ADI administration, the age range of affected subjects
was 2.8–25.3 years (mean 6.6 years, SD 3.5 years,
25th–75th percentile 4.3–7.6 years). The mean nonver-
bal IQ was 61 (SD 23, range 15–124). Sixty-two subjects
(63%) had IQ scores !70. Mean MA was 47 mo (SD
23 mo, range 13–150 mo). Again, there were no families
in which all children had IQ scores !30, and there were
three children with MA !18 mo.
The unaffected children were presumed to be devel-
oping normally, on the basis of parental report; all of
these children were in regular educational programs and
schools. None had any clinical diagnoses, according to
parental report, nor, during telephone intake interviews,
did parents report any developmental concerns.Children
with a possible PDD diagnosis based on the ADI inter-
view but who did not meet the ADI criteria for autism
were categorized as being of uncertain status and were
not included in this analysis. Eighty-eight percent of our
sample was white (of varied European and Middle East-
ern origin), 5% was black, 3% was Hispanic, and 4%
was Asian. The vast majority of affected subjects were
living with parents, and a small number were in resi-
dential living facilities.
FS1: Pointwise IBD Scores
A total of 346 autosomal, 14 X-linked, and 2 pseu-
doautosomal microsatellite loci were studied in FS1,
which contained 97 independent ASPs and 51 indepen-
dent DSPs. Tallying the total number of alleles shared
across all 346 autosomal markers gives 19,902/38,572,
or 51.6%, for the ASPs and 9,344/18,386, or 50.8%,
for the DSPs. The slight increase in IBD, to 150%, in
the DSPs suggests the possibility of some modest scoring
bias toward allele sharing in sibships.
Of greatest interest is the right-hand tail of the ob-
served IBD distribution in the ASPs and DSPs. For each
marker, we calculated a Z score, ,Z  (s u)/ s u
where s is the number of shared alleles and u is the
number of unshared alleles. Under the null hypothesis
of no linkage, Z should have a normal distribution with
mean 0 and variance 1. When a threshold of 1.96
( for a one-sided Z test) is assumed, there areP  .025
9 loci in the ASP group that exceed this threshold and
10 loci in the DSP group that exceed this threshold,
which are listed in table 2. These numbers are not dif-
ferent from the number expected ( ).025# 360  9.0
under the null hypothesis of no linkage. The most sig-
nificant locus, in either group, was D1S1631, for the
ASPs, with a sharing of 65.6% and a Z score of 3.44.
The remaining loci in the ASP group were found on
chromosomes 1 (two additional loci), 3, 9, 10, 13, 15,
and 17. The locus on chromosome 15, D15S652, is telo-
meric of and not linked to the candidate region, on prox-
imal 15q, associated with the inverted duplication found
in some autistic subjects (Gillberg et al. 1991; Cook et
al. 1997). Aside from locus D1S1631, there appears to
be no substantial difference between the tail Z scores
for the ASP group and those for the DSP group.
We also examined the full distribution of Z scores,
for both the ASPs and the DSPs. These distributions are
given in figure 1. For convenience, we have plotted each
Z score as a function of , where R is the11F [(R )/S]2
ordered rank of that Z score, is the total numberS  346
of autosomal markers, and F is the cumulative normal-
distribution function. Under the null hypothesis (no link-
age), this curve should fit the line . In figure 1, they  x
line is depicted as the thin unbroken line; the thicky  x
dotted line represents DSPs, and the thick dashed line
represents ASPs. As can be seen in the figure, both the
ASP and DSP lines run parallel but above the line y 
, but more so in the case of the ASP line. This indicatesx
that the entire distribution of Z scores for the ASPs is
shifted upward, compared with that for the DSPs, and
this shift is most noticeable at the left end of the distri-
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bution (i.e., deficiency of negative sharing). The final
“blip” at the right end of the ASP line is due to marker
D1S1631.
Observed versus Expected Distribution Of IBD Scores
As discussed above, family and twin studies suggest
that autism is a highly heritable disorder. However, these
data alone cannot reveal the precise mode of inheritance.
The very high MZ:DZ concordance ratio, taken at face
value, is strongly suggestive of multiple interacting loci
(epistasis), with no single locus having a substantial ef-
fect. The results of our initial genome screen would seem
to support this conclusion. However, given the high re-
currence-risk ratio for sibs ( ) and the highl  75–100S
(15–25) MZ:DZ concordance ratio, one may reasonably
ask what the distribution of IBD scores would look like
for various genetic models consistent with those values.
For the purpose of computational simplification, we as-
sume a multiplicative epistatic model (Risch 1990) with
K loci of equal effect. Given the 15–25 MZ:DZ con-
cordance ratio, models with as few as two loci can be
excluded. For a model with K loci, the ith locus will
have an individual value of for
1
Kl  (l ) i  1,) ,KSi S
(Risch 1990). The ASP sharing yi at each of these loci
will be according to a
1 1 
2 2Ky  1 .5(l )  1 .5(l )i Si S
multiplicative model. For example, for ,K  3 y i
; for , ; for ,75.7% K  5 y  67.5% K  10 y i i
; and, for , . If , then59.7% K  20 y  55.1% l  150i S
the corresponding yi values for , 5, 10, and 20 areK  3
only slightly higher—namely, 78.3%, 69.7%, 61.1%,
and 55.9%, respectively. Similar numbers can be ob-
tained by parameterization in terms of the MZ:DZ con-
cordance ratio, which we here denote as “lMD.” Ac-
cording to a multiplicative model, for K contributing
loci of equal effect, the total lMD is (lMDi)
K, where lMDi
is the ratio contributed by the ith locus. Furthermore,
the expected ASP IBD sharing for a locus with value lMDi
is given simply by . Since, in a model with1y  li MDi2
K loci of equal effect, for , we
1
Kl  (l ) i  1,) ,KMDi MD
can calculate the expected sharing, under the assumption
that , for , 5, 10, and 20 as being 85.5%,l  25 K  3MD
69.0%, 58.7%, and 54.2%, respectively. It can be seen
that these numbers are larger than those based on the
sib risk ratio for smaller K values (i.e., !5) but that they
begin to converge at .K 1 5
Certainly our data are not consistent with a three-
locus model, since we do not have three regions with
sharing approaching 70%. Recombination will tend to
decrease sharing away from these high values, but, given
our map density, it is unlikely that the sharing would be
significantly diminished. In fact, we can calculate sys-
tematically, making some simplifying assumptions, what
the distribution of sharing (and associated Z scores)
should be under these alternative genetic models.
Consider the distribution of Z scores derived from a
genome screen. For a given marker, Z is defined, as
above, as . Under the null hypothesis of(s u)/ s u
no linkage, Z is approximately normally distributed,
with mean 0 and variance 1. Now consider a genetic
model of K disease loci, each of which has sharing yi.
We assume that the loci are unlinked. Assume a genetic
map with a marker everyw cM. On average, the distance
of a disease locus to the closest marker will be ; thew4
distances to remaining markers, in order of distance, are
, , , etc. For a marker at recombination distance3w 5w 7w4 4 4
r from a disease locus, the sharing will be 2y(r)  [r 
. Thus, assuming a map2(1 r) ]y 2r(1 r)(1 y)
function relating recombination fraction r to map dis-
tance w—for example, —we can calculate ther  f(w)
expected values of sharing y for markers surrounding a
disease locus.
In the present analysis, we assume the Kosambi map-
ping function . As in4w 4wr  f(w)  (1 e )/2(1 e )
our screen, we assume a map density of 10 cM, with a
total map length of 3,500 cM. For each of K putative
disease loci, we estimate sharing y(r) at neighboring loci
at distances 2.5 cM, 7.5 cM, 12.5 cM,), up to 47.5
cM, using the Kosambi map function and the y(r) for-
mula given above.
For the model with K loci of equal effect, there are K
loci each with value y(r), where y(r) ranges over the 10
values based on the 10 different marker distances. In our
genome screen of ASPs, the average total number of
transmissions scored at a locus was 110 (i.e., , ins u
the notation above). Therefore, for the K markers with
expected sharing y(r), we used sampling from a normal
distribution with mean y(r) and variance v(r) 
to obtain the expected distributiony(r)[1 y(r)]/110
of their observed sharing. We selected the K points from
this distribution to be equally spaced to preserve the
mean y(r) and variance v(r). For example, for weK  5
chose the five points ,y (r)  y(r) 2v(r) y (r) 1 2
, , , and y(r) v(r)/2 y (r)  y(r) y (r)  y(r) v(r)/23 4
. These five points have sampley (r)  y(r) 2v(r)5
mean y(r) and variance v(r). For the jth such point, the
expected Z score was then derived by taking Z (r) j
. As an example,12 110[y (r) ]  10.49[2y (r) 1]j j2
consider the genetic model with , , and thel  75 K  5S
third-closest marker (12.5 cM). For this case, y 
, , , , ,.675 r  .122 y(r)  .600 y (r)  .534 y (r)  .5671 2
, , and ;y (r)  .600 y (r)  .633 y (r)  .666 Z (r) 3 4 5 1
, , , , and.71 Z (r)  1.41 Z (r)  2.10 Z (r)  2.792 3 4
.Z (r)  3.485
In this fashion, Z scores for 10K markers were de-
rived. For the remaining markers, we dis-346 10K
tributed their Z scores as above but according to a nor-
mal distribution with mean 0 and variance 1. We have
calculated these expected distributions, assuming that
and . The results for , 5, 10,l  75 K  3–20 K  3S
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Figure 2 Observed distribution of Z scores for sharing at 346
autosomal marker loci in ASPs, compared with the expected distri-
bution, when a model of , 5, 10, or 20 loci of equal effect isK  3
assumed. The thick unbroken line represents no linkage; the thick
dashed line represents the observed data for ASPs; the thin long-dashed
line represents ; the thin dotted line represents ; the thinK  3 K  5
short-dashed line represents ; the thin unbroken line representsK  10
.K  20
and 20 are given in figure 2. As in figure 1, we have
plotted the Z scores as a function of ,11F [(R )/S]2
where R is the rank of the observed Z score and S is
the total number of markers (346). A normal distribu-
tion appears as a straight line ( ) on this plot and,y  x
in figure 2, is depicted by the thick unbroken line. The
expected curve corresponding to is given by theK  3
thin dashed lined, for by the thin dotted line, forK  5
by the thin short-dashed line, and forK  10 K  20
by the thin unbroken line. The curve for the actual data
is given by the thick dashed line. In calculating the Z
scores for the actual data, we used 50.8% for expected
sharing under the null hypothesis, instead of 50%, to
allow for some potential genotyping bias, as observed
in the DSPs. As can be seen in figure 2, the actual data
most closely approximate the expectations for the model
with . The fact that the thick dashed line liesK  20
above the line at the left end of the plot indicatesy  x
that the excess sharing in ASPs compared with DSPs is
due to the entire distribution being shifted to the right,
rather than to a small subset of marker loci showing
increased sharing. The right end of the plot, although
reasonably consistent with , is quite deviant fromK  20
the distribution expected for or 10, with the ex-K  5
ception of the final marker (D1S1631). For other values
of K, the distributions lie between the curves in figure
2. For example, for the distribution lies ap-K  15
proximately midway between the line for andK  10
that for ; for the distribution is somewhatK  20 K  13
closer to the line for .K  10
To assess goodness of fit of each predicted distribution
to the observed distribution, we calculated the statistic
, where Zi1 is the ith (rank-ordered)
346 2W  S (Z  Z )i1 i1 i0
Z score for the expected distribution and Zi0 is the cor-
responding Z score for the observed distribution. A small
value of W indicates a good fit of the observed distri-
bution to the predicted distribution. The corresponding
value of W for values of , 5, 10, 13, 15, 17, andK  3
20 is 53.1, 16.7, 5.1, 3.6, 3.1, 2.8, and 2.7, respectively.
Thus, models with 10 loci appear unlikely, whereas
those with15 seem more plausible. The best fit is given
by the model with loci, although the value ofK  20
W does not increase much up to . Models spec-K  15
ifying a small number of loci (i.e., one or two) with
moderate effect ( ) also give a reasonable fit (al-l  2S
though not as good as is given by the model of 20 loci
with equal effect), provided that the number of residual
loci remains large (e.g., 15). Thus, our results, al-
though consistent with a genetic basis of autism, suggest
that the most likely model is one with many (15) con-
tributing loci, with a possible gene of larger effect on
chromosome 1.
In calculating the expected distributions, we have
made a number of simplifying assumptions, such as
equal spacing and equal polymorphism of the markers.
Most significant among these assumptions, however, is
that the disease-susceptibility loci are unlinked, which
will be unlikely for models with . The effect ofK  20
having linked disease loci is to increase sharing locally
in the region of the linked loci—and to decrease it, on
average, elsewhere. Thus, the impact will be to create a
distribution more similar to the case of fewer disease loci
with larger effect. Therefore, our modeling is actually
conservative in concluding that the observed distribution
is most compatible with a large number of disease loci.
Sharing by Gender of Parent
The observation of genomewide excess sharing and a
putative model of many genes of small effect accounting
for the total familial effect in autism allow us to posit
a further prediction. If, in fact, there are many genes
scattered around the genome, then the excess of sharing
that we have observed should differ when tallied sepa-
rately for paternal versus maternal meioses. The reason
is that the female linkage map, at 4,200 cM, is ∼1.5
times the genetic length of the male map, at 2,800 cM.
Because there is globally less recombination in males,
the expected genetic distance (recombination fraction
[v]) to a disease-susceptibility locus in males is expected
to be less than that in females, and thus the expected
allele sharing at a marker linked to the disease locus is
expected to be greater when one examines fathers than
when one examines mothers.
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Table 3
Global Allele Sharing in ASPs and DSPs, by Sex of Parent and Genetic
Map–Interval Male:Female Ratio
SEX RATIO
(Male:Female)
NO. (%) SHARING
Paternal Maternal
ASPs:
11 (85 markers) 2,336/4,560 (51.2) 2,413/4,712 (51.2)
!1 (261 markers) 7,459/14,275 (52.3) 7,694/15,025 (51.2)
Total 9,795/18,835 (52.0) 10,107/19,737 (51.2)
Total (maternal  paternal) 19,902/38,572 (51.6)
DSPs:
11 (85 markers) 1,110/2,160 (51.4) 1,167/2,304 (50.7)
!1 (261 markers) 3,401/6,722 (50.6) 3,666/7,200 (50.9)
Total 4,511/8,882 (50.8) 4,833/9,504 (50.9)
Total (maternal  paternal) 9,344/18,386 (50.8)
To quantitate this prediction, define ,1d(0)  y 2
where y is the sharing at a disease locus. Then, at
v distance, the value of y is 2 2y(v)  [v  (1 v) ]y
, so that 12v(1 v)(1 y) d(v)  y(v)  (12
. If we assume a uniform distribution for the22v) d(0)
map distance, w, from a random marker locus to the
nearest disease locus, then, over some total map length
L, the expected value of d is
L
1 2E(d)  d(0)[1 2v(w)] dw ,L
0
wherew is some mapping function relating map distance
to v. For the Haldane mapping function v(w)  (1
, , for2w 4Le )/2 E(d)  d(0)(1 e )/L  d(0)/L L 1 50
cM. Similarly, for the Kosambi mapping function
,4w 4w 2L 1v(w)  (e  1)/2(e  1) E(d)  d(0)[(1 e ) 
for12Llog(1 e ) log2 ]/L  .193d(0)/L L 1 502
cM. In either case, . Therefore, if female map1E(d) ∝ L
distances are 1.5 times male map distances and if we let
dm represent the d value for male (paternal) meioses and
let df represent that for female meioses, then we have
. Therefore, when the observed sharingE(d )/E(d ) ∝ 1.5m f
rate of .508 (from the discordant pairs) is used as the
null value, the observed sharing for concordant pairs,
.516, gives a sex-averaged value of . There-E(d)  .008
fore, the prediction discussed above would give sex- spe-
cific E(d) values of and , orE(d )  .010 E(d )  .006m f
sex-specific sharing values of andy  51.8% y m f
. If we use 50% for the null-hypothesis sharing51.4%
value, then the sex-specific sharing becomes y m
and .51.9% y  51.3%f
The observed total sharing for ASPs, stratified by sex
of parent, is andy  9,795/18,835  52.0% y m f
(table 3), close to the predic-10,107/19,737  51.2%
tion. For comparison, we also examined the parent-spe-
cific allele sharing for the DSPs. There was no difference
in overall allele sharing, by sex of parent, for this group
(50.8% paternal, 50.9% maternal).
We can make this prediction more precise by noting
that the male:female ratio of map distances is not uni-
form throughout the genome but, rather, is region spe-
cific. Some regions (e.g., telomeres) tend to show an ex-
cess of recombination in males. Thus, we would expect
the observed excess of paternal allele sharing to be re-
stricted to those regions where the female map distances
exceed those of the male. To test this hypothesis, we
identified the location of each of the 346 marker loci on
the Marshfield genetic maps (Center for Medical Ge-
netics, MarshfieldMedical Research Foundation). By ex-
amining, for each locus, flanking markers up to 10 cM
away (sex averaged), we determined whether the genetic
length of the flanking interval was greater inmales (male:
female ratio 11) or in females (male:female !1). As ex-
pected, the number of markers with a male:female ratio
11 ( ) was approximately one-third the numbern  85
with a male:female ratio !1 ( ). As predicted, then  261
paternal excess of sharing in ASPs was restricted to
markers lying in regions with a male:female ratio !1
(52.3% paternal sharing vs. 51.2% maternal sharing)
(table 3). Again, the DSPs showed no such trend, since
the paternal and maternal sharing were nearly equal in
both groups (table 3).
Multipoint Sib-Pair Analysis in FS1
We performed multipoint sib-pair analysis on the data
from FS1, for the 360 autosomal and X-linked markers
of MS1. The results are shown in figure 3. In the figure,
the MLS curve is represented by the dashed line. There
were nine locations that gave an MLS 1.0: chromo-
somes 1p (MLS 1.87), 1q (MLS 1.19), 7p (MLS 1.00),
11p (MLS 1.25), 13q (MLS 1.49), 15q (MLS 1.75), 17p
(MLS 1.30), 18q (MLS 1.00), and 20p (MLS 1.09). The
MLS on chromosome 1p was diminished comparedwith
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the significance obtained with marker D1S1631 (table
2), because of less sharing at neighboring markers.
These results are consistent with those shown in fig-
ures 1 and 2, in that no regions revealed linkage evidence
that was near significance, even when a liberal criterion
of MLS 3.0 was used. Thus, it is unlikely that any genes
of moderate to large effect underlie this disorder.
Follow-up in FS2
The 49 families of FS2, comprising 50 ASPs, were
analyzed for a total of 149 markers, 60 of which were
original (i.e., MS1) markers typed in FS1. A total of 157
additional markers (MS2) were typed in FS1; 89 of these
were also typed in FS2. Many new markers were typed
only in FS1, either to fill in larger gaps in the original
screen or to increase marker density in certain candidate
regions, in particular on chromosomes 6p and 15q. On
the basis of preliminary positive results in the first stage
of analysis, markers were added on chromosomes 1 (two
regions), 3, 9, 10, 13, 15, and 17.
Results of multipoint analysis of the combined data
from both FS1 and FS2, for all 517 autosomal and X-
linked loci, are given in figure 3 (the MLS curve for the
total data is represented by the unbroken line; the ex-
clusion curve fixing is represented by the dottedl  3.0Si
line). The linkage evidence, in FS2, for markers on prox-
imal chromosome 1p was positive, with allele sharing
of 50%–66% (average 56%); in FS1, maximal sharing
in multipoint analysis was observed near marker
D1S1631. With the inclusion of FS2 and additional
markers in this region, the MLS of 2.15 now occurs at
a slightly more proximal location (near marker
D1S1675). This location gives, by far, the strongest link-
age evidence in our study. The next most significant re-
sult is on chromosome 17p, where the MLS peaked at
1.21, near marker D17S1876. Only two other regions
had an MLS 1.0, one each on chromosome 7p (MLS
1.01, near marker D7S2564) and 18q (MLS 1.00, near
marker D18S878). All other regions with MLS 1.0 in
the initial scan were less positive in FS2, leading to a
reduction in the total MLS for FS1 and FS2 combined.
Notably, only chromosome 1p had substantially positive
allele sharing in FS2, leading to a modest increase in the
MLS for FS1 and FS2 combined.
Proximal chromosome 15q is a candidate region for
an autism-susceptibility locus, because of reported in-
verted duplications in a number of patients (Gillberg et
al. 1991; Cook et al. 1997). Furthermore, some positive
linkage results were reported in this region in a small
collection of multiplex families (Pericak-Vance et al.
1997). We previously have reported that, in this region
of chromosome 15, there is a lack of linkage evidence
in the 97 FS1 ASPs (Salmon et al., in press). The addition
of 50 ASPs from FS2 has not altered this conclusion,
since our linkage evidence is still uniformly negative
across the entire region (fig. 3). The positive linkage
results that we obtained on this chromosome were near
marker D15S1050, which is 62 cM away.
We have also previously reported a lack of linkage
evidence with markers in the HLA region on chromo-
some 6p in FS1 (Rogers et al., in press). The data in this
region remain negative with the addition of FS2.
In a previous analysis of 38 of the ASPs included in
the present study, we examined markers on the X chro-
mosome. Although we excluded most of the chromo-
some, including the fragile X region, from harboring a
gene of large effect, a region of Xq did show modest
evidence of linkage, with a LOD score of 1.24. In the
present study, based on a much larger number of fam-
ilies, there is no evidence of linkage anywhere on the X
chromosome.
A genome screen of 39 multiplex families with autism,
with follow-up in an additional 60 families, found sug-
gestive evidence of linkage on chromosomes 7q and 16p
(International Molecular Genetic Study of Autism Con-
sortium 1998). The MLS in the same region of 7q is
0.62 (for marker D7S684), on the basis of a total of 139
families and 147 ASPs. We had a slightly more positive
result at marker D7S1804 (MLS 0.93), located 10.3 cM
more proximal. The original study had an MLS of 2.53.
Thus, if a susceptibility locus resides in this region, its
effect is likely to be small, given the modest LOD scores
observed.
In our initial scan (i.e., with FS1), a region of chro-
mosome 13q had an MLS of 1.65, near marker
D13S779. In our follow-up, the linkage evidence at this
location was negative (46.3% sharing); however, a re-
gion of modestly increased sharing appeared somewhat
distal in the same area, with an MLS of 0.68, near
marker D13S800 (fig. 3). This region has also been re-
ported in another recent genome screen (Vieland et al.
1998). Again, the modest level of linkage evidence in
our collection of 147 ASPs suggests that a gene of large
effect in this region is unlikely.
Using a strict exclusion criterion of 2 (Hauser et al.
1996), we were able to exclude ∼95% of the genome,
for a value of (fig. 3). When the less strictl  3.0Si
exclusion criterion of 1 was used, 99% of the genome
could be excluded.
Positive Controls
In our study, we had initially included two twin pairs
originally thought to be DZ but subsequently, through
our genotyping, shown to be MZ. These subjects were
left in the study as a positive control and to estimate the
rate of genotyping error. The individuals performing ge-
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Figure 3 Multipoint sib-pair analysis of ASPs. The dashed line represents the MLS for FS1 with MS1; the unbroken line represents the
MLS for FS1  FS2, with all markers; the dotted line represents the exclusion plot for , with all families and markers.l  3.0S
notyping were blinded to the status of these subjects.
Considering a total of 946 loci scored for these two pairs,
we found them to be genotypically discordant at 10 loci,
or a rate of 1.0%. It should be noted that, in our study,
families were analyzed intact, so that some genotyping
errors (Mendelian inconsistencies) could be identified.
These Mendelian inconsistencies were identified and cor-
rected (by additional genotyping, if necessary) and were
not included in the error rate given above.
As a second positive control, we included the pseu-
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Figure 4 Observed distribution of P values from TDT tests for
519 markers for affected and unaffected offspring. The straight un-
broken line represents expectation under no LD; the dashed line rep-
resents unaffected offspring; the jagged unbroken line represents af-
fected offspring.
doautosomal marker DXYS154. This marker is com-
pletely linked to sex, since it does not recombine between
the X and Y chromosomes. In our study, we had a large
predominance of affected males (male:female ratio 3.6:
1 in FS1 and 2.8:1 in FS2). Thus, a majority of our ASPs
are brother pairs, whereas a minority are sister pairs or
of mixed sex. Overall, 73% of our ASPs are concordant
for sex (63% males and 10% females). Therefore, we
expect, at locus DXYS154, excess sharing of alleles in-
herited from the fathers, but not of those inherited from
the mothers. In FS1 and FS2 combined, there were 58
paternal alleles shared and 22 paternal alleles not shared,
giving a x2 of 16.2 (the LOD score equivalent of which
is 3.52). By contrast, there was no difference in the shar-
ing of maternal alleles: 42 alleles were shared and 45
alleles were not shared. The significantly increased shar-
ing of paternal alleles at this marker demonstrates that
our methodology was sufficiently sensitive to detect a
real excess of sharing of this magnitude (i.e., 73%) when
such an excess was present.
LD
We performed TDTs for all 517 autosomal and X-
linked loci analyzed in this study. Here we report the
results of the GCS test (see the Linkage-Disequilibrium
analysis [LD] subsection, above). In figure 4 we have
plotted the distribution of observed (empirically derived)
P values, as a function of their rank. Under the null
hypothesis of no LD, the distribution of P values should
be uniform, and thus this plot should approximate the
line , which, in figure 4, is represented by they  x
straight unbroken solid line; the values for affected off-
spring are represented by the dashed line, and those for
unaffected offspring are represented as the jagged un-
broken line. As can be seen in the figure, for theP ! .05
observed and expected distributions are the same for the
two types of offspring and fit the line well. Thesey  x
results are not unexpected, in that it is a priori unlikely
that a disease locus would lie very close to and in LD
Discussion
We have performed a genomic screen by linkage anal-
ysis of 90 multiplex sibships with autism, including 97
independent ASPs, with 360 autosomal and X-linked
markers. Regions that, in this screen, initially either (a)
had positive results, (b) had gaps, or (c) were identified
as specific candidate regions were subjected to follow-
up with additional markers. We also genotyped a second
set of 49 multiplex sibships (50 ASPs), with markers in
specific target regions. In total, 519 markers were run
on FS1, and 149 were run on FS2. More than 160,000
genotypes were generated.
Analysis of allelic sharing for the initial 360 markers
in FS1 was most consistent with a multigenic inheritance
pattern, in that a global excess of allele sharing was
observed in the ASPs versus the DSPs, but not specifically
for a small number of loci. The overall distribution of
allele sharing was most consistent with a model of 15
susceptibility loci.
These results are not inconsistent with the observed
recurrence risks in nuclear families and twins. The very
high (25-fold) MZ:DZ concordance ratio is indicative
of at least several interacting loci and, potentially, of
many such loci. Multilocus inheritance does not preclude
the possibility of one or a few loci with larger effects;
there is a limit, however, on how large these effects can
be, given our modest linkage findings. A previous study
of family recurrence risks in autism found a model with
3 interactive loci as providing the best fit to the data,
with a range of 2–10 loci (Pickles et al. 1995). Our
results clearly exclude a model with as few as 3 loci and
are also inconsistent with a model with as few as 10
loci.
Our results also do not preclude the possibility of
etiologic heterogeneity, with a subset of cases having a
simpler (e.g., Mendelian) etiology. However, as ex-
plained above, such a group would need to be relatively
minor, given both our results and the large MZ:DZ con-
cordance ratio.
Our most significant findings were for proximal chro-
mosome 1p. The most significant increase in sharing in
our initial screen was for marker D1S1631, with 66%
sharing and a Z score of 3.44 (table 2). The multipoint
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analysis of FS1 brought this score down to an MLS of
1.88; however, this region was also the most positive in
our follow-up and, in 147 ASPs, gave a total MLS of
2.15 and sharing of 60%. We note, however, that this
result falls short of formal statistical significance for a
genome screen (Lander and Kruglyak 1995). The MLS
location after follow-up was somewhat more proximal
than that in the initial screen, near marker D1S1675.
No other region had an MLS 11.3 in our follow-up.
Our next most significant finding was for chromosome
17p, where theMLS was 1.21. We had modestly positive
LOD scores in regions identified in other genome
screens—chromosomes 7q and 13q. Our results for
chromosome 15q, in the Prader-Willi region, which, on
the basis of cytogenetic evidence, is a candidate region
for an autism–susceptibility locus, were uniformly neg-
ative, consistent with our earlier results (Salmon et al.,
in press). However, in our initial screen, we did identify
another region, more distal on chromosome 15q, that
had an MLS of 1.75; but, in the follow-up, the MLS in
this region decreased to 0.81.
We employed several controls in this study, to identify
potential biases. First, we analyzed unaffected siblings
in our multiplex sibships, to create a comparison group
for our linkage and LD results. Second, we kept two
pairs of MZ twins, originally thought to be DZ, in the
genotyping set, as a positive control for our genotyping,
as well as to estimate the error rate in genotyping. Fi-
nally, we included a pseudoautosomal marker com-
pletely linked to sex, as a positive control, reflecting the
excess of sex-concordant (primarily brother) pairs in our
study. As predicted, this marker showed a clear, statis-
tically significant paternal excess of sharing (MLS 3.52).
These controls provide confidence in the validity of our
conclusions.
We also took a conservative approach to phenotyping.
All study subjects were evaluated by both ADI assess-
ment and ADOS assessment, and all questionable cases
were excluded from analysis. Furthermore, to reduce po-
tential heterogeneity, we excluded families in which all
affected children had extremely low IQ, since this group
may have distinct etiologies related to their severe-to-
profound mental retardation. In total, we excluded 45
families from further analysis. The primary reason for
the family exclusions was that not all affected sibs had
a strict diagnosis of autism, as defined by agreement of
all diagnosticians. As a result, the families in our study
included few broadly defined, questionable, or mild
cases (e.g., clinical diagnoses of either PDD-NOS or As-
perger syndrome), even though most of the children in
these excluded families did exhibit symptoms and be-
haviors indicative of the autism spectrum, some at the
very high end of the spectrum and some at the very low
end.
We employed these conservative diagnostic rules for
inclusion within the study, which were applied equally
to all affected subjects in a family, for two reasons. First,
we wanted to enhance our chances of detecting any link-
age, by creating a more homogeneous set of families.
Second, we wanted to gain confidence that any negative
results that we might obtain would not be due to the
use of a too-broad diagnostic spectrum whose genetic
basis is still uncertain (even though a number of recent
family studies of autism probands suggest the presence
of a broad range of mild behavioral symptoms and pos-
sibly related disorders in these families [Bailey et al.
1998]). Although our exclusion of “mild” or autism
“spectrum” cases might be questioned by some who ar-
gue strongly for their inclusion within genetic studies,
the only negative effect that this exclusion would have
on our analysis would be to reduce the sample size. A
homogeneous group of strictly defined affected subjects
should maximize the chances of detection of linkage, for
any plausible genetic model.
Although our genomic-screen results are largely neg-
ative, in that we did not identify a chromosomal region
with significant linkage evidence, we have not formally
excluded the possibility of one or a few disease-predis-
posing loci of moderate effect. On the basis of our re-
sults, the most likely location for such a locus or loci is
on chromosome 1p—and, possibly, on chromosome
17p. We are currently examining these regions more
closely. However, given the lack of strong linkage evi-
dence in this large collection of families, positional clon-
ing of any susceptibility genes in this disorder may be a
difficult undertaking, and other approaches, such as LD
studies of candidate genes and/or genomewide associa-
tion studies may be required.
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